TipRanks
Vicapsys Life Sciences Inc (VICP)
OTHER OTC:VICP
US Market
VICP
Vicapsys Life Sciences
RESEARCH TOOLSreports

Vicapsys Life Sciences (VICP) Income Statement

2 Followers

Vicapsys Life Sciences Income Statement

Last quarter (Q1 2026), Vicapsys Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Vicapsys Life Sciences's net income was $-104.57K. See Vicapsys Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -31.29K$ -31.33K
Operating Expenses
$ 651.80K$ 813.84K$ 1.05M$ 644.56K$ 336.87K
Depreciation and Amortization
$ 0.00$ 0.00$ 31.29K$ 31.29K$ 31.33K
EBITDA
$ -651.80K$ -900.14K$ -1.02M$ -613.27K$ -305.54K
Operating Income
$ -651.80K$ -813.84K$ -1.05M$ -984.79K$ -336.87K
Other Income/Expenses
$ -38.08K$ -175.96K$ -135.13K$ -340.23K$ 100.00K
Pretax Income
$ -689.89K$ -989.80K$ -1.18M$ -984.79K$ -236.87K
Net Income
$ -689.89K$ -989.80K$ -1.18M$ -984.79K$ -236.87K
Per Share Metrics
Basic EPS
$ -0.02$ -0.03$ -0.03$ -0.03$ -0.01
Diluted EPS
$ -0.02$ -0.03$ -0.03$ -0.03$ -0.01
Weighted Average Shares Outstanding
 35.37M 34.33M 34.55M 30.58M 17.66M
Weighted Average Shares Outstanding (Diluted)
 35.37M 34.33M 34.55M 30.58M 17.66M
Currency in USD

Vicapsys Life Sciences Earnings and Revenue History